Arkolith/Insider Trading/VRDN/Form 4

Fairmount Funds Management LLC

Director, 10% OwnerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Jun 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2025Option exercise(M)13K$12.31$154K3.5M
Jun 9, 2025Option exercise(M)2K$7.80$12K3.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 10, 2025Option exercise(M)13K—$00
Jun 9, 2025Option exercise(M)2K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-058580) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML